HOME
ABOUT US
FOUNDATION
ADVERTISING
PRESS-RELEASES
NEWSLETTERS
EU PROJECTS
ACTIVITY REPORTS
INTERNATIONALIZATION
RESOURCES
NEWS
CONFERENCES
JOBS
PH REPORTS
GRAPHENE CLUSTER
EVENTS
Nanobalkan2023
Ramanfest2023
NanoBio&Med2023
QUANTUMatter2024
Graphene2024
UPCOMING
ARCHIVE
CONTACT
News
Researchers develop blood-brain-barrier-permeable nanoparticles for Alzheimer's disease treatment
[
23-08-2022
]
Alzheimer´s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions. Current treatments for AD that focus on inhibition of amyloid beta (Aβ) aggregation failed to show effectiveness in people with AD symptoms.
Related News
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000
[
22-09-2023
]
Nanobiotechnology, Nanomedicine
NBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform
[
19-09-2023
]
Nanomedicine, Graphene
Nanoneedle breakthrough gives hope for cheaper cancer treatment
[
24-08-2023
]
Nanomedicine, Nanotechnologies
Nanovesicles from cells for biomedical applications
[
17-01-2023
]
Nanobiotechnology, Nanomedicine
Wireless brain implant monitors neurotransmitters in real-time
[
16-01-2023
]
Nanomaterials, Nanobiotechnology, Nanomedicine
CLOSE
Sitemap
HOME
ABOUT US
FOUNDATION
ADVERTISING
PRESS-RELEASES
NEWSLETTERS
EU PROJECTS
ACTIVITY REPORTS
Internationalization
RESOURCES
NEWS
CONFERENCES
JOBS
PH REPORTS
GRAPH. CLUSTER
EVENTS
NANOBALKAN2023
RAMANFEST2023
NanoBio&Med2023
QUANTUMatter2024
Graphene2024
UPCOMING
ARCHIVE
CONTACT
PRIVACY POLICY
Tweets por @PhantomsNet
© Phantoms Foundation 2023